Sleep and Breathing Health supplied 99% of segment profit growth.
ResMed's two reporting businesses earned $613.79 M in operating profit this quarter, up $29.15 M, and Sleep and Breathing Health supplied $28.87 M of that rise, or 99%. The software business, Residential Care Software, booked $54.30 M, barely higher than a year earlier. Its sales fell 7%, and the filing says that drop was predominantly the sale of MatrixCare. Is its profit holding because the business is healthy, or because the sold unit took its costs with it?
Management's explanation is clean: the decrease was predominantly due to the sale of MatrixCare, which closed on September 1, 2026, partly offset by growth in its MEDIFOX DAN and Brightree verticals. The filing gives no revenue figure for MatrixCare, so that drop cannot be checked against the numbers. Restructuring is kept out of the segments: Note 12 says both businesses were hit, but its $19 M of charges are not allocated to either one. One customer, 11% of total net revenue, is booked in both businesses.
Goodwill, the premium paid for past acquisitions, is the quiet exposure here: $1.81 B of it sits in the software business, out of $2.91 B across ResMed. The segment note reports sales and profit for each business, but no goodwill, so that split has to come from elsewhere. The MD&A says the sale also cut amortization of acquired intangibles, which flatters the margin. If that business keeps shrinking after its biggest sale, will its goodwill still hold its value?

